Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03358810 · ClinicalTrials.gov registry record · NA
Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke
A NA study, sponsored by Phagenesis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03358810: Completed NA study, sponsored by Phagenesis.
NCT03358810 is a NA study that has completed, run by Phagenesis. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03358810, a NA study, has completed, sponsored by Phagenesis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a randomized, sham-controlled, patient masked, outcome assessor-blinded study to assess a Pharyngeal Electrical Stimulation (PES) Catheter for treatment of oropharyngeal dysphagia following a stroke.
Primary Outcome
VFSS (Vidoeflouroscopic Swallow Study) Swallowing safety of a bolus of thin and nectar consistency determined by a videofluoroscopic swallowing study.The PAS provides a scoring mechanism for airway closure and clearance during the VFSS. The PAS is a validated 8-point scale that measures penetration and aspiration. Scores are determined primarily by the depth to which material passes into the airway. 1. Material does not enter airway 2. Material enters the airway, remains above the vocal folds,
Interventions
- DEVICE PES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-31 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
What the finished NCT03358810 record still lists
NCT03358810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which PES is the first listed.
NCT03358810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03358810 about?
NCT03358810 is a clinical study titled "Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke". This is a randomized, sham-controlled, patient masked, outcome assessor-blinded study to assess a Pharyngeal Electrical Stimulation (PES) Catheter for treatment of oropharyngeal dysphagia following a stroke.
What is the current status of trial NCT03358810?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-03-31. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT03358810?
The interventions under investigation include: PES (DEVICE).
Who is sponsoring clinical trial NCT03358810?
This trial is sponsored by Phagenesis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03358810's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI